Inhale-3 Study Results to be Presented During a 90-Minute Symposium on Saturday, June 22 at the American Diabetes Association’s 84th Scientific Sessions

4d ago

MNKD

PremiumPress Releases

MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix

11d ago

MNKD

PremiumPress Releases

MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

1M ago

MNKD

PremiumPre-Earnings

Is MNKD a Buy, Before Earnings?

1M ago

MNKD

PremiumPress Releases

MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024

1M ago

MNKD

PremiumPress Releases

MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases

1M ago

MNKD

PremiumPress Releases

MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease

1M ago

MNKD

More MNKD News >

MNKD News on the Web

2024-06-05

Inhale-3 Study Results to be Presented During a 90-Minute Symposium on Saturday, June 22 at the American Diabetes Association’s 84th Scientific Sessions

Yahoo Finance

Neutral

2024-05-29

MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix

Yahoo Finance

Neutral

2024-05-29

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

Yahoo Finance

Neutral

2024-05-13

MannKind Upgraded to Strong Buy: Here's Why

Yahoo Finance

Neutral

2024-05-13

MannKind (MNKD) Upgraded to Strong Buy: Here's Why

Zacks

Bullish

2024-05-10

MannKind First Quarter 2024 Earnings: Beats Expectations

Yahoo Finance

Neutral

2024-05-10

MannKind Corp (MNKD) Q1 2024 Earnings Call Transcript Highlights: A Quarter of Robust Growth ...

GuruFocus News

Bullish

2024-05-10

MannKind Corp Q1 2024 Earnings Call Transcript Highlights: A Quarter of Robust Growth ...

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

MNKD

Sector Average

Media Buzz

This Week1 articles

Weekly Average1.25 articles

News Sentiment

This Week50%

Sector Average59%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MNKD’s Media Buzz Sentiment?

1 articles about MNKD were published this week. In an average week, 1.25 articles are published.

What is MNKD’s weekly average amount of articles?

In an average week, 1.25 articles about MNKD are published.

What is MNKD’s News Sentiment?

50% of articles about MNKD were positive this week, compared to its sector average of 59%.

Healthcare Stocks that are Trending in the News

ANNXAnnexon Biosciences

GERNGeron

BMEABiomea Fusion

GPCRStructure Therapeutics, Inc. Sponsored ADR

MASIMasimo

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing